A recombinant vaccinia-rabies virus in the immunocompromised host: oral innocuity, progressive parenteral infection, and therapeutics
- 1 February 1997
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 15 (2), 140-148
- https://doi.org/10.1016/s0264-410x(96)00163-6
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Vaccine technologies: view to the futureScience, 1994
- Control of Rabies in WildlifeScientific American, 1992
- Chemotherapy of the acquired immune deficiency syndrome (AIDS): Acyclic nucleoside phosphonate analoguesInternational Journal of Immunopharmacology, 1991
- X-linked severe combined immunodeficiencyClinical Immunology and Immunopathology, 1991
- The SCID Mouse Mutant: Definition, Characterization, and Potential UsesAnnual Review of Immunology, 1991
- Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaignResearch in Virology, 1989
- Vaccinia Virus Expression VectorsAnnals of the New York Academy of Sciences, 1989
- Vaccinia virus: a suitable vehicle for recombinant vaccines?Archiv für die gesamte Virusforschung, 1989
- Disseminated Vaccinia in a Military Recruit with Human Immunodeficiency Virus (HIV) DiseaseNew England Journal of Medicine, 1987
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981